Menu

Reports

picture26

Shortage of HIV/AIDS drugs in South Africa

Home/Reports | Posted 13/12/2013

According to a survey of South African clinics, one in five of them are running short of life-saving HIV/AIDS drugs, affecting nearly half a million people and undermining the success of the world’s largest treatment programme.

Meds Cost Euros 1 V13L06

OECD report finds reduction in spending on health

Home/Reports | Posted 06/12/2013

Spending on health fell in one of three countries covered by the Organisation for Economic Co-operation and Development (OECD) between 2009 and 2011, with the countries hit hardest by the financial crisis witnessing the biggest cuts.

picture 112

American-made prescription drugs 76% cheaper when purchased abroad

Home/Reports | Posted 15/11/2013

American patients can make significant savings by buying drugs abroad, according to an analysis carried out by online pharmacy information specialist PharmacyChecker.com.

Patient MD002316 V13C05

Biosimilars: what patients need to know

Home/Reports | Posted 08/11/2013

Biosimilars are medicines that are similar to a biological medicine that has already been authorized. Biosimilars are different to generics in that they are not identical to their reference product. This is due to the fact that they are derived from living cells and therefore demonstrate molecular complexity and heterogeneity. For this reason biosimilars must be ‘similar but not identical’ to their reference biological with regards to quality, safety, and efficacy.

Endocrinology 1 V13J31

Endocrinologists need more data to prescribe biosimilars

Home/Reports | Posted 31/10/2013

Endocrinologists require more clinical trial data for biosimilars compared to other specialists, such as oncologists and gastroenterologists, according to a report from research and advisory firm BioTrends Research Group.

picture 116

Gastroenterologists unlikely to use infliximab biosimilar

Home/Reports | Posted 18/10/2013

Gastroenterologists are unlikely to prescribe an infliximab biosimilar in their Crohn’s disease or ulcerative colitis patients if it has not been clinically tested in inflammatory bowel diseases, according to a report from a research and advisory firm.

picture30

Increased use of generics could save South Africa millions

Home/Reports | Posted 11/10/2013

Increasing the use of generics by 5% could save the healthcare industry and patients in South Africa in excess of Rand 400 million per year, according to a report from the country’s pharmaceutical association.

UK flag V13I20

UK biosimilars uptake lower than in some other EU countries

Home/Reports | Posted 20/09/2013

Use of biosimilars in the UK is lower than might be expected when looking at the use of generics in the UK, and it is lower than in some other European countries.

Generics Blue Cap V13C15

India’s pharma moving from generics to niche drugs

Home/Reports | Posted 13/09/2013

Indian pharmaceutical companies will increasingly move away from the overcrowded and competitive area of generics and invest more R & D spending in niche drugs, according to a new report.

ANDA Approval V13F21

Authorized generics reduce drug prices

Home/Reports | Posted 06/09/2013

In what seems to be a bit of a turnaround for the US Federal Trade Commission (FTC), the agency has released a report which suggests that authorized generics can reduce both retail and wholesale drug prices.